265 related articles for article (PubMed ID: 26457433)
1. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
Kong L; Torrents de la Peña A; Deller MC; Garces F; Sliepen K; Hua Y; Stanfield RL; Sanders RW; Wilson IA
Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2099-108. PubMed ID: 26457433
[TBL] [Abstract][Full Text] [Related]
2. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike.
Scharf L; Scheid JF; Lee JH; West AP; Chen C; Gao H; Gnanapragasam PN; Mares R; Seaman MS; Ward AB; Nussenzweig MC; Bjorkman PJ
Cell Rep; 2014 May; 7(3):785-95. PubMed ID: 24767986
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.
Ahmed S; Shrivastava T; Kumar R; Kumar M; Banerjee M; Kumar N; Bansal M; Das S; Samal S
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129733. PubMed ID: 32949621
[TBL] [Abstract][Full Text] [Related]
4. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.
Behrens AJ; Kumar A; Medina-Ramirez M; Cupo A; Marshall K; Cruz Portillo VM; Harvey DJ; Ozorowski G; Zitzmann N; Wilson IA; Ward AB; Struwe WB; Moore JP; Sanders RW; Crispin M
J Proteome Res; 2018 Mar; 17(3):987-999. PubMed ID: 29420040
[TBL] [Abstract][Full Text] [Related]
5. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.
Schoofs T; Barnes CO; Suh-Toma N; Golijanin J; Schommers P; Gruell H; West AP; Bach F; Lee YE; Nogueira L; Georgiev IS; Bailer RT; Czartoski J; Mascola JR; Seaman MS; McElrath MJ; Doria-Rose NA; Klein F; Nussenzweig MC; Bjorkman PJ
Immunity; 2019 Jun; 50(6):1513-1529.e9. PubMed ID: 31126879
[TBL] [Abstract][Full Text] [Related]
6. Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env.
Scharf L; Wang H; Gao H; Chen S; McDowall AW; Bjorkman PJ
Cell; 2015 Sep; 162(6):1379-90. PubMed ID: 26359989
[TBL] [Abstract][Full Text] [Related]
7. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
[TBL] [Abstract][Full Text] [Related]
8. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.
Gristick HB; von Boehmer L; West AP; Schamber M; Gazumyan A; Golijanin J; Seaman MS; Fätkenheuer G; Klein F; Nussenzweig MC; Bjorkman PJ
Nat Struct Mol Biol; 2016 Oct; 23(10):906-915. PubMed ID: 27617431
[TBL] [Abstract][Full Text] [Related]
9. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
[TBL] [Abstract][Full Text] [Related]
10. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Dubrovskaya V; Tran K; Ozorowski G; Guenaga J; Wilson R; Bale S; Cottrell CA; Turner HL; Seabright G; O'Dell S; Torres JL; Yang L; Feng Y; Leaman DP; Vázquez Bernat N; Liban T; Louder M; McKee K; Bailer RT; Movsesyan A; Doria-Rose NA; Pancera M; Karlsson Hedestam GB; Zwick MB; Crispin M; Mascola JR; Ward AB; Wyatt RT
Immunity; 2019 Nov; 51(5):915-929.e7. PubMed ID: 31732167
[TBL] [Abstract][Full Text] [Related]
12. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer.
Gristick HB; Wang H; Bjorkman PJ
Acta Crystallogr D Struct Biol; 2017 Oct; 73(Pt 10):822-828. PubMed ID: 28994411
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y
J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.
Julien JP; Lee JH; Cupo A; Murin CD; Derking R; Hoffenberg S; Caulfield MJ; King CR; Marozsan AJ; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4351-6. PubMed ID: 23426631
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a soluble cleaved HIV-1 envelope trimer.
Julien JP; Cupo A; Sok D; Stanfield RL; Lyumkis D; Deller MC; Klasse PJ; Burton DR; Sanders RW; Moore JP; Ward AB; Wilson IA
Science; 2013 Dec; 342(6165):1477-83. PubMed ID: 24179159
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
Moyo T; Ereño-Orbea J; Jacob RA; Pavillet CE; Kariuki SM; Tangie EN; Julien JP; Dorfman JR
J Virol; 2018 Jul; 92(14):. PubMed ID: 29618644
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
Crooks ET; Tong T; Chakrabarti B; Narayan K; Georgiev IS; Menis S; Huang X; Kulp D; Osawa K; Muranaka J; Stewart-Jones G; Destefano J; O'Dell S; LaBranche C; Robinson JE; Montefiori DC; McKee K; Du SX; Doria-Rose N; Kwong PD; Mascola JR; Zhu P; Schief WR; Wyatt RT; Whalen RG; Binley JM
PLoS Pathog; 2015 May; 11(5):e1004932. PubMed ID: 26023780
[TBL] [Abstract][Full Text] [Related]
18. A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
Zhou T; Zheng A; Baxa U; Chuang GY; Georgiev IS; Kong R; O'Dell S; Shahzad-Ul-Hussan S; Shen CH; Tsybovsky Y; Bailer RT; Gift SK; Louder MK; McKee K; Rawi R; Stevenson CH; Stewart-Jones GBE; Taft JD; Waltari E; Yang Y; Zhang B; Shivatare SS; Shivatare VS; Lee CD; Wu CY; ; Mullikin JC; Bewley CA; Burton DR; Polonis VR; Shapiro L; Wong CH; Mascola JR; Kwong PD; Wu X
Immunity; 2018 Mar; 48(3):500-513.e6. PubMed ID: 29548671
[TBL] [Abstract][Full Text] [Related]
19. Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.
Zhang Z; Wang Q; Nguyen HT; Chen HC; Chiu TJ; Smith Iii AB; Sodroski JG
J Virol; 2023 Sep; 97(9):e0059223. PubMed ID: 37696048
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope.
Barnes CO; Gristick HB; Freund NT; Escolano A; Lyubimov AY; Hartweger H; West AP; Cohen AE; Nussenzweig MC; Bjorkman PJ
Nat Commun; 2018 Mar; 9(1):1251. PubMed ID: 29593217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
